Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
HLA-DRB1*15:01 and Epstein-Barr virus in a multiple sclerosis patient with psoriasis, nasopharyngeal and breast cancers. Lessons for possible hidden links for autoimmunity and cancer.
Consequences of neurologic lesions assessed by Barthel Index after Botox(®) injection may be underestimated.
Substitutions mimicking deimination and phosphorylation of 18.5-kDa myelin basic protein exert local structural effects that subtly influence its global folding.
Prevalence of Incidental Narrowing of the Superior Segment of the Internal Jugular Vein in Patients Without Multiple Sclerosis.
Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.
Country break-out session highlights.
Patient satisfaction with the BETACONNECT™ autoinjector for interferon beta-1b.
Gray matter damage predicts the accumulation of disability 13 years later in MS.
Serial electrophysiological studies in a Guillain-Barré subtype with bilateral facial neuropathy.
Environmental factors related to multiple sclerosis in Indian population.
Patient assessment within the context of healthcare delivery packages: A comparative analysis.
How can cognitive reserve in multiple sclerosis inform clinical care?
Neurological disorders: Differential methylation in multiple sclerosis.
An adaptive clinical trials procedure for a sensitive subgroup examined in the multiple sclerosis context.
Golli Myelin Basic Proteins Modulate Voltage-Operated Ca(++) Influx and Development in Cortical and Hippocampal Neurons.
Evolution of diagnostic criteria for multiple sclerosis.
Mode of action and clinical studies with fumarates in multiple sclerosis.
High dose antigen treatment with a peptide epitope of myelin basic protein modulates T cells in multiple sclerosis patients.
Elevated and dysregulated bone morphogenic proteins in immune cells of patients with relapsing-remitting multiple sclerosis.
Differential screening-selected gene aberrative in neuroblastoma (DAN) is increased in the CSF of patients with MS and may be induced by therapy with interferon-β.
Intrathecal Baclofen Dosing Regimens: A Retrospective Chart Review.
Molecular interplay between T-Antigen and splicing factor, arginine/serine-rich 1 (SRSF1) controls JC virus gene expression in glial cells.
What Do Effective Treatments for Multiple Sclerosis Tell Us about the Molecular Mechanisms Involved in Pathogenesis?
Multiple sclerosis: 7 T MRI reveals cortical lesions associated with disability in MS.
Multiple sclerosis in Isfahan, Iran: an update.
Pages
« first
‹ previous
…
531
532
533
534
535
536
537
538
539
…
next ›
last »